These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 8502697

  • 21. New diagnostic assays for the detection of HDV-RNA and HDV-antibodies.
    Kos A, Bonelli F, Dubbeld M, Slachmuylders J, Palla M.
    Prog Clin Biol Res; 1993; 382():325-8. PubMed ID: 8502698
    [No Abstract] [Full Text] [Related]

  • 22. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis.
    Rosina F, Saracco G, Lattore V, Quartarone V, Rizzetto M, Verme G, Trinchero P, Sansalvadore F, Smedile A.
    Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384
    [No Abstract] [Full Text] [Related]

  • 23. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
    Kleiner D, Di Bisceglie AM, Axiotis CA, Hoofnagle JH.
    Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
    [Abstract] [Full Text] [Related]

  • 24. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF, Hsieh SY, Chien RN, Chen TJ, Sheen IS, Chu CM.
    Prog Clin Biol Res; 1993; 382():229-34. PubMed ID: 8502686
    [No Abstract] [Full Text] [Related]

  • 25. [The hepatitis D virus and its role in the evolution of hepatitis B].
    Antipa C.
    Rev Roum Virol; 1992; 43(1-2):87-93. PubMed ID: 1288644
    [No Abstract] [Full Text] [Related]

  • 26. [Delta hepatitis virus (HDV) marker].
    Inoue O, Yano M.
    Nihon Rinsho; 1999 Nov; 57 Suppl():356-8. PubMed ID: 10635856
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Viral hepatitis in HIV infection.
    Cross TJ, Taylor CB, Harrison PM.
    N Engl J Med; 2007 Jul 05; 357(1):90; author reply 91. PubMed ID: 17611215
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Hepatitis due to HDV infections].
    Walewska-Zielecka B, Nazarewicz-de Mezer T, Nowosławski A.
    Patol Pol; 1990 Jul 05; 41(4):157-63. PubMed ID: 2152516
    [Abstract] [Full Text] [Related]

  • 31. [The delta agent and its value in hepatic pathology in children].
    Maggiore G.
    Arch Fr Pediatr; 1986 Jan 05; 43(1):55-9. PubMed ID: 3518650
    [No Abstract] [Full Text] [Related]

  • 32. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J, Takahashi M, Nishizawa T, Narantuya L, Sakuma M, Kagawa Y, Shimosegawa T, Okamoto H.
    J Med Virol; 2005 Jul 05; 76(3):333-40. PubMed ID: 15902700
    [Abstract] [Full Text] [Related]

  • 33. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
    Aragona M, Macagno S, Caredda F, Crivelli O, Lavarini C, Bertolusso L, Farci P, Rizzetto M.
    Prog Clin Biol Res; 1987 Jul 05; 234():243-8. PubMed ID: 3628379
    [No Abstract] [Full Text] [Related]

  • 34. [Serologic diagnosis of hepatitis caused by A or B virus and the delta agent].
    Ramírez-Mayans JA, Mariño-Forero A, Maldonado-Rayas J, Rivera-Echegoyen M, Casaubon-Garcin P.
    Bol Med Hosp Infant Mex; 1988 Jun 05; 45(6):394-402. PubMed ID: 2844202
    [No Abstract] [Full Text] [Related]

  • 35. Modulation of hepatitis delta virus infection by vaccination with synthetic peptides: a preliminary study in the woodchuck model.
    Bergmann KF, Casey JL, Tennant BC, Gerin JL.
    Prog Clin Biol Res; 1993 Jun 05; 382():181-7. PubMed ID: 8502677
    [No Abstract] [Full Text] [Related]

  • 36. Diagnosis of hepatitis delta virus infection.
    Rodríguez M, Martínez A, Sala P, Riestra S, Suárez A, Rodrigo L.
    Hepatology; 1991 Jan 05; 13(1):204-5. PubMed ID: 1846345
    [No Abstract] [Full Text] [Related]

  • 37. [Hepatitis D: clinical course and serology].
    Garassini S MA.
    Rev Gastroenterol Mex; 1995 Jan 05; 60(4 Suppl 2):S43-5. PubMed ID: 8948776
    [No Abstract] [Full Text] [Related]

  • 38. Acute delta hepatitis in Greek parenteral drug abusers.
    Tassopoulos NC, Koutelou MG, Papatheodoridis GV, Kalantzakis YS, Hatzakis AE.
    Prog Clin Biol Res; 1993 Jan 05; 382():221-7. PubMed ID: 8502685
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical significance of hepatitis delta virus marker analysis].
    Yotsumoto S, Omi S, Okada S, Okamoto H.
    Nihon Rinsho; 1990 Feb 05; 48 Suppl():304-8. PubMed ID: 2355548
    [No Abstract] [Full Text] [Related]

  • 40. Genetically engineered molecular probes in the study of the natural history of chronic delta hepatitis.
    Monjardino J, Saldanha J, Goldin R, Thomas HC.
    Prog Clin Biol Res; 1991 Feb 05; 364():197-9. PubMed ID: 2020695
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.